THE EFFECTS OF INSULIN ON CHOLESTEROL-SYNTHESIS IN TYPE-II DIABETIC-PATIENTS

被引：0
|
作者：
SCOPPOLA, A
LALA, A
FRONTONI, S
RICCI, A
GAMBARDELLA, S
MENZINGER, G
机构：
[1] UNIV ROMA LA SAPIENZA,DIPARTIMENTO STUDI CHIM TECN SOST BIOL ATT,I-00185 ROME,ITALY
[2] UNIV ROMA TOR VERGATA,CATTEDRA ENDOCRINOL,ROME,ITALY
来源：
DIABETOLOGIA | 1993年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A194 / A194
页数：1
相关论文
共 50 条
  • [21] EARLY-ONSET OF PHARMACODYNAMIC EFFECTS OF GLIMEPIRIDE IN TYPE-II DIABETIC-PATIENTS
    WERNICKEPANTEN, K
    HAUPT, E
    PFEIFFER, C
    MAYER, A
    DRAEGER, KE
    DIABETOLOGIA, 1994, 37 : A163 - A163
  • [22] EFFECTS OF ANTIHYPERTENSIVE AGENTS ON ALBUMIN EXCRETION IN TYPE-II DIABETIC-PATIENTS - REPLY
    STORNELLO, M
    VALVO, EV
    SCAPELLATO, L
    CLINICAL SCIENCE, 1992, 83 (04) : 510 - 510
  • [23] LIPOPROTEIN COMPOSITIONAL ABNORMALITIES AND INSULIN-RESISTANCE IN TYPE-II DIABETIC-PATIENTS WITH MILD HYPERLIPIDEMIA
    STEWART, MW
    LAKER, MF
    DYER, RG
    GAME, F
    MITCHESON, J
    WINOCOUR, PH
    ALBERTI, KGMM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (07): : 1046 - 1052
  • [24] TRANSDERMAL INSULIN APPLICATION IN TYPE-II DIABETIC-PATIENTS - RESULTS OF A CLINICAL PILOT-STUDY
    LIEDTKE, RK
    SORGER, M
    MERK, F
    VETTER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-2 (08): : 884 - 886
  • [25] EXOGENOUS INSULIN RETARDS RATE OF WEIGHT-LOSS IN OBESE TYPE-II DIABETIC-PATIENTS
    HARRIS, MD
    DAVIDSON, MB
    BUSH, MA
    INTERNATIONAL JOURNAL OF OBESITY, 1985, 9 (04) : A40 - A40
  • [26] ROLE OF GLUCOSE AND INSULIN ON CALCIUM HANDLING IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT HYPERTENSION AND MICROALBUMINURIA
    SOLINI, A
    DIVIRGILIO, F
    TREVISAN, M
    CIPOLLINA, MR
    NOSADINI, R
    CREPALDI, G
    DIABETOLOGIA, 1994, 37 : A46 - A46
  • [27] EXOGENOUS INSULIN RETARDS RATE OF WEIGHT-LOSS IN OBESE TYPE-II DIABETIC-PATIENTS
    HARRIS, MD
    DAVIDSON, MB
    BUSH, MA
    CLINICAL RESEARCH, 1986, 34 (01): : A59 - A59
  • [28] INVOLVEMENT OF PROSTAGLANDINS IN THE ACTION OF CAPTOPRIL IN TYPE-II DIABETIC-PATIENTS
    KOEV, D
    ZACHARIEVA, S
    ANDONOVA, K
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1989, 93 (01): : 11 - 18
  • [29] PLASMA MEVALONATE AND CHOLESTEROGENESIS IN NORMOLIPIDEMIC TYPE-II DIABETIC-PATIENTS
    SCOPPOLA, A
    FRONTONI, S
    CASELLI, A
    TESTA, G
    LALA, A
    DIABETOLOGIA, 1995, 38 : A248 - A248
  • [30] ATTENUATED FIBRINOLYSIS AND ACCELERATED ATHEROGENESIS IN TYPE-II DIABETIC-PATIENTS
    SCHNEIDER, DJ
    NORDT, TK
    SOBEL, BE
    DIABETES, 1993, 42 (01) : 1 - 7
12345